ABT News and Press, Abbott Laboratories

2026-07-12 09:33:02 ET Read the full article on Seeking Alpha For further details see: Earnings week ahead: JPM, C, BAC, WFC, MS, UNH, JNJ, ABT, UAL, GS, TSM, and more

2026-07-11 11:00:00 ET Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings re...

2026-07-11 09:35:48 ET PepsiCo Q2: Why The Dividend Story Is Still Intact PepsiCo, Inc. (PEP) Q2 2026 Earnings Call Transcript Why You Want PepsiCo To Miss Earnings This Week Delta Air Lines Non-GAAP EPS of $1.56 beats by $0.06, revenue of $19.8B beats by $950M ...

2026-07-10 17:55:32 ET Introduction The Dividend Champions list is a monthly compilation of companies that have consistently increased their annual dividend payouts. However, since this list is only produced once per month, the data in it can quickly get out of date. Furthermore, wi...

2026-07-10 15:00:57 ET More on JPMorgan Chase, United Airlines, etc. JPMorgan Chase: Buy Ahead Of Q2 Report On Credit Market And Profits Netflix: A Knife Actually Worth Catching Netflix Q2 Preview: Live Programming Presents Opportunity, Shares A Hold Netflix ...

2026-07-10 08:25:56 ET More on markets 25 stocks up over 25% in 2026 that all analysts agree are Buys Slower AI payoff poses broad risks for markets and the economy, Apollo warns Citi sees the next Fed move as a hike and not a cut, amid reduced guidance US3...

2026-07-08 17:23:46 ET Should you stick with a diversified healthcare titan or a specialized high-growth challenger? Here is how Abbott Laboratories (NYSE:ABT) and Glaukos (NYSE:GKOS) stack up for investors looking ahead into 2026. Abbott operates as a global leader acro...

2026-07-08 17:12:48 ET More on Big Pharma Johnson & Johnson: Stronger Fundamentals, But Too Much Optimism Novo Nordisk Loses Its Edge, And I'm Downgrading Novartis' Pipeline Building Continues, Pelacarsen Readout Coming Soon Moderna appoints Michael McDon...

2026-07-08 07:00:04 ET More on State Street Health Care Select Sector SPDR ETF Soft Landing Myth: How This Week's Data Exposed The Hidden Recession Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It AI Revolutionizing Biopharma: Faster, Bette...

2026-07-07 17:50:00 ET Demand for GLP-1 medicines is booming, as these drugs have proven highly effective at treating diabetes, obesity, and other conditions. Investors looking to capitalize on this may turn to the current leaders in the GLP-1 market: Eli Lilly (NYSE: LLY) and Nov...